These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 833606)

  • 1. Preliminary estimates of the dopamine beta-hydroxylase content and activity in purified noradrenergic vesicles.
    Klein RL; Kirksey DF; Rush RA; Goldstein M
    J Neurochem; 1977 Jan; 28(1):81-6. PubMed ID: 833606
    [No Abstract]   [Full Text] [Related]  

  • 2. Latency of dopamine beta-hydroxylase in purified noradrenergic vesicles.
    Kirksey DF; Klein RL; Thureson-Klein A; White HB
    Neuroscience; 1977; 2(4):621-34. PubMed ID: 917286
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydrophilic form of dopamine beta-hydroxylase from purified noradrenergic vesicles. Activities and comparisons.
    Gasparis MS; Yang WH; Klein RL
    Neurochem Res; 1983 Nov; 8(11):1417-39. PubMed ID: 6419138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the development of sympathetic nerve trunk vesicles during axonal transport: density gradient analysis of dopamine beta-hydroxylase in bovine splenic nerve.
    Lagercrantz H; Kirksey DF; Klein RL
    J Neurochem; 1974 Oct; 23(4):769-73. PubMed ID: 4430916
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical observations on the formation of small noradrenergic vesicles in the splenic nerve of the dog.
    De Potter WP; Chubb IW
    Neuroscience; 1977; 2(1):167-74. PubMed ID: 917275
    [No Abstract]   [Full Text] [Related]  

  • 6. Are opioid peptides co-transmitters in noradrenergic vesicles of sympathetic nerves?
    Wilson SP; Klein RL; Chang KJ; Gasparis MS; Viveros OH; Yang WH
    Nature; 1980 Dec; 288(5792):707-9. PubMed ID: 6109254
    [No Abstract]   [Full Text] [Related]  

  • 7. The turnover rate of noradrenergic vesicles.
    De Potter WP; Chubb IW
    Biochem J; 1971 Nov; 125(1):375-6. PubMed ID: 5158920
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular control of the uptake, storage and release of noradrenaline in sympathetic nerves.
    Smith AD
    Biochem Soc Symp; 1972; (36):103-31. PubMed ID: 4374949
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromogranins in sympathetic nerves.
    Banks P; Helle KB
    Philos Trans R Soc Lond B Biol Sci; 1971 Jun; 261(839):305-10. PubMed ID: 4399623
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid peptides and noradrenaline co-exist in large dense-cored vesicles from sympathetic nerve.
    Klein RL; Wilson SP; Dzielak DJ; Yang WH; Viveros OH
    Neuroscience; 1982; 7(9):2255-61. PubMed ID: 7145093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tyramine and guanethidine on dopamine-beta-hydroxylase activity and norepinephrine concentrations in vesicular fraction of the heart and plasma of rats.
    Grobecker H; Roizen MF; Kopin IJ
    Life Sci; 1977 Mar; 20(6):1009-15. PubMed ID: 850457
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for the presence of dopamine- -hydroxylase in both populations of noradrenaline storage vesicles in sympathetic nerve terminals of the rat vas deferens.
    Bisby MA; Fillenz M; Smith AD
    J Neurochem; 1973 Jan; 20(1):245-8. PubMed ID: 4734484
    [No Abstract]   [Full Text] [Related]  

  • 13. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. II. Effects of papaverine.
    Cubeddu L; Barnes E; Weiner N
    J Pharmacol Exp Ther; 1974 Dec; 191(3):444-57. PubMed ID: 4372339
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors.
    Cubeddu L; Barnes EM; Langer SZ; Weiner N
    J Pharmacol Exp Ther; 1974 Sep; 190(3):431-50. PubMed ID: 4153469
    [No Abstract]   [Full Text] [Related]  

  • 15. Nerve stimulation-meditated overflow of norepinephrine and dopamine-beta-hydroxylase. III. Effects of norepinephrine depletion on the alpha presynaptic regulation of release.
    Cubeddu L; Weiner N
    J Pharmacol Exp Ther; 1975 Jan; 192(1):1-14. PubMed ID: 235629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal transport of muscarinic receptors in vesicles containing noradrenaline and dopamine-beta-hydroxylase.
    Laduron PM
    FEBS Lett; 1984 Jan; 165(1):128-32. PubMed ID: 6198205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological aspects of peripheral noradrenergic transmission.
    de Potter WP; Chubb IW; de Schaepdryver AF
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:258-. PubMed ID: 4342946
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of adrenergic nerve terminals: the effects of decentralization.
    Mytilineou C; Black IB
    Brain Res; 1978 Dec; 158(2):259-68. PubMed ID: 30522
    [No Abstract]   [Full Text] [Related]  

  • 19. Newly synthesized norepinephrine accumulation in the readily releasable pool of a purified adrenergic vesicle fraction.
    Klein RL; Harden TK
    Life Sci; 1975 Jan; 16(2):315-22. PubMed ID: 1110607
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional distribution of tyrosine hydroxylase and dopamine beta-hydroxylase activities in guinea pig heart.
    Dickson DW; Lund DD; Subieta AR; Prall JL; Schmid PG; Roskoski R
    J Auton Nerv Syst; 1981 Nov; 4(4):319-26. PubMed ID: 6118385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.